Our People - Screening Supervisor
Welcome to our July edition, celebrating the contributions of Kathline Shaw, our Screening Supervisor.
"When I moved to Australia in 2017, Nucleus Network was the first and only company I applied to; I was fortunate to join their Clinical Operations team as a Clinical Unit Assistant.
This role served as my launchpad into a more challenging position, progressing over a year to become a Screening Supervisor at the Melbourne site.
I was entrusted with significant opportunities and responsibilities that accelerated my professional growth.
Working at Nucleus Network, my joy lies in collaborating with genuine and remarkable individuals. Amidst challenges, the support and camaraderie of my colleagues make difficult times more manageable.?
Over the span of 7 years, I have witnessed how the company prioritizes honing the skill sets of its team members and provides diverse growth opportunities.?
I take immense pride in being part of a company that contributes to advancing medicine and improving lives."
Kathline Shaw - Screening Supervisor
The Screening department aims to ensure that potential eligible subjects are screened for participation in clinical trials, and that the process undertaken to screen the subject is conducted in accordance with protocol requirements and Good Clinical Practice guidelines.
In addition, the Screening department is responsible for performing outpatient (OP) visits as per study protocol requirements.
Thank you, Kathline, for sharing your experience and your ongoing contributions to Nucleus Network! We are very grateful to have you on our team!
Advance your career with us!
These are our current open opportunities, click the links below to learn more and apply:
MELBOURNE
BRISBANE
If you have any questions, please email [email protected]
领英推荐
Our Facilities
We are the world's first and only multi-site, multi-country Phase 1 clinical trials specialist with Phase 1 facilities in Australia and the USA.
Spanning three cities - Brisbane, Melbourne and Minneapolis
Brisbane
Our Brisbane facility is Australia's second-largest Phase 1 clinical trials facility, housing a total of 60 beds.
Specializing in vaccine and biosimilar studies, our Brisbane facility has a purpose-built infrastructure to support the high-volume participant and outpatient requirements of these clinical trial designs. This facility is also supported by external bioanalytical and pharmacodynamic laboratories.
Melbourne
Our Melbourne facility is Australia's largest Phase 1 clinical trials facility in the country, housing a total of 94 beds and co located within the Alfred Hospital (800 bed hospital).
Specializing in first in human clinical trials, our Melbourne facility has extensive pharmacodynamic biomarker capabilities, including on-site access to imaging facilities, respiratory facilities (bronchoscopy suites), gastroenterology facilities (endoscopy suites) and anesthetic services (lumbar punctures and pain models)
Pharmacodynamic capabilities also extend to immunology services (including flow cytometry and immune activation) and bioanalytical services, through onsite external vendors.
Minneapolis
Our Minneapolis 50 bed Phase 1 facility is located in the heart of Minneapolis metropolitan area and specializes in the conduct of healthy studies as well as complex patient studies, including onsite dialysis for patients with severe renal impairment.
The long-term partnerships with private clinicians and specialty groups throughout Minnesota provides us with unique access to various patient populations which are not readily available in other Phase 1 facilities.
We would love to hear from you!
If you have any questions, please do not hesitate to contact me.
Have a lovely month ahead!
Kind regards,
Natalie
Chief Executive Officer
4 个月We are lucky to have you in our team Kathline Shaw